Abstract
The bioavailability of insulin from a nasal formulation with 5% glycofurol (GF) was studied in vivo in rabbits. A pronounced decrease in the plasma glucose level, comparable to the response for Novolin® Nasal, was observed. A nadir after 30 min was observed where the plasma glucose was 59% of the initial value. The potential for local side effect from 5% GF was found to be very low in the frog-palate model, where the mucociliary clearance rate was only reduced 9%.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
